Clinical Trials with Pegylated Liposomal Doxorubicin in the Treatment of Ovarian Cancer

Among the pharmaceutical options available for treatment of ovarian cancer, increasing attention has been progressively focused on pegylated liposomal doxorubicin (PLD), whose unique formulation prolongs the persistence of the drug in the circulation and potentiates intratumor accumulation. Pegylate...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Pisano, Carmela, Cecere, Sabrina Chiara, Di Napoli, Marilena, Cavaliere, Carla, Tambaro, Rosa, Facchini, Gaetano, Scaffa, Cono, Losito, Simona, Pizzolorusso, Antonio, Pignata, Sandro
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi Publishing Corporation 2013
Témata:
Review Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3612436/
https://ncbi.nlm.nih.gov/pubmed/23577259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/898146
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky